US pension fund San Francisco Employees’ Retirement System (SFERS) has approved a capital commitment of up to $48 million to two investment vehicles launched by China-based biomedical venture capital firm Lilly Asia Ventures (LAV).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
